GT Biopharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-1.5M | $-1.5M | — | $149.0K |
| FY2011 | $-963.0K | $-963.0K | $0 | $307.0K |
| FY2012 | $-987.0K | $-989.0K | $2.0K | $929.0K |
| FY2013 | $-442.0K | $-442.0K | $0 | $176.0K |
| FY2014 | $-1.7M | $-1.8M | $6.0K | $2.6M |
| FY2015 | $-4.7M | $-4.7M | $1.0K | $3.8M |
| FY2016 | $-1.9M | $-1.9M | $0 | $6.6M |
| FY2017 | $-5.4M | $-5.4M | $4.0K | $130.1M |
| FY2018 | $-10.7M | $-10.7M | $36.0K | $9.7M |
| FY2019 | $-3.7M | $-3.7M | $0 | $5.3M |
| FY2020 | $-7.3M | $-7.3M | — | $269.0K |
| FY2021 | $-15.6M | $-15.6M | — | $33.9M |
| FY2022 | $-15.2M | $-15.2M | — | $7.7M |
| FY2023 | $-8.9M | $-8.9M | — | — |
| FY2024 | $-12.9M | $-12.9M | — | $230.0K |
| FY2025 | $-12.9M | $-12.9M | — | $432.0K |